MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

The novel STAT3 inhibitor WZ-2-033 causes regression of human

Inhibition of EZH2 Catalytic Activity Selectively Targets a

BAY-8002, a Monocarboxylate Transporter 1 Inhibitor for Cancer Research

triple-negative breast cancer MedChemExpress (MCE) Life Science

Arnicolide D Inhibits Triple Negative Breast Cancer Cell

MC2590, a Potent HDAC Inhibitor, inhibits HDAC1-3, -6, -8, and -10

XL092 is a Potent Axl, Mer and C-Met kinase Inhibitor

BI-3406 is an Orally Active and Selective KRAS and SOS1 Interaction Inhibitor

triple-negative breast cancer MedChemExpress (MCE) Life Science

BM-1197 is a Potent and Selective Dual Bcl-2/Bcl-xL Inhibitor

CXD101 is a Selective and Orally Active Class I HDAC Inhibitor

OT-82 is an Orally Active NAMPT Inhibitor with Antineoplastic Activity